Biopharma · FDA Approvals · Stock
MTNB Matinas BioPharma
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Catalyst calendar
Dated catalysts for MTNB, including recently decided ones.
Nothing scheduled in this window.
Recent first-hand events
Every first-hand event for MTNB, newest first.
Instant stream — events appear as soon as they are filed.
Decision-gradeMaterialNotableMinor
No events yet.
Peers by market cap
Companies in the same sector closest to MTNB in market value.
OGENOragenicsMarket cap $1.7M · 1 tracked drug
KAPAKairos PharmaMarket cap $1.8M · 2 tracked drugs
GNPXGenprexMarket cap $1.8M · 1 tracked drug · 3 upcoming catalystsEEDVAEndovia Health SciencesMarket cap $1.9M · 1 tracked drug · 1 upcoming catalyst
JAGXJaguar HealthMarket cap $842.5K · 1 tracked drug · 3 upcoming catalysts
LNAILunai BioworksMarket cap $747.2K
DCOYDecoy TherapeuticsMarket cap $701.0K · 2 tracked drugs
REVBRevelation BiosciencesMarket cap $2.3M · 1 tracked drug